Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fresenius Kabi Australia is a leading healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company provides a comprehensive portfolio of essential pharmaceuticals, including generic intravenous drugs, infusion therapies, and an expanding range of biosimilars. They are a key supplier to Australian hospitals and healthcare facilities, focusing on the care of critically and chronically ill patients. Their operations include local manufacturing and compounding services, ensuring the availability of vital healthcare products across the region. In addition to pharmaceuticals, the company offers medical devices such as infusion pumps and sets for the administration of their therapies. As a subsidiary of the global Fresenius Kabi group, they leverage international research and development to bring advanced treatments to the Australian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fresenius Kabi Australia.